Due to the similarity between the antigenic targets, it was suggested that CYP17-Abs and CYP21-Abs have immunological cross-reactivity (314), but subsequent studies in sera from patients with APS1 disproved this hypothesis (315, 316). Here, CYP17A1 is linked to Autoimmune polyendocrinopathy type 1.